Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth R Chapman

Showing results (131-140 of 176) with videos related to

Pageof 18
Sort By:
Lancet (London, England)|June 1, 2015
Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trialKenneth R Chapman, Jonathan G W Burdon, Eeva Piitulainen, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|April 30, 2020
Reducing the hidden burden of severe asthma: recognition and referrals from primary practiceMarc Humbert, Arnaud Bourdin, Nikolaos G Papadopoulos, et al.
Journal of Asthma and Allergy|January 30, 2023
Mometasone/Indacaterol/Glycopyrronium (MF/IND/GLY) and MF/IND at Different MF Strengths versus Fluticasone Propionate/Salmeterol Xinafoate (FLU/SAL) and FLU/SAL+ Tiotropium in Patients with AsthmaRichard N van Zyl-Smit, Kenneth R Chapman, Huib A M Kerstjens, et al.
Respiratory Research|May 11, 2021
Benefit of switching to mepolizumab from omalizumab in severe eosinophilic asthma based on patient characteristicsMark C Liu, Bradley Chipps, Xavier Munoz, et al.
Plos One|April 5, 2013
Bronchodilator responsiveness and reported respiratory symptoms in an adult populationWan C Tan, Jean Bourbeau, Paul Hernandez, et al.
Chest|April 13, 2006
The Ontario Asthma Regional Variation Study: emergency department visit rates and the relation to hospitalization ratesM Diane Lougheed, Nancy Garvey, Kenneth R Chapman, et al.
Chest|November 20, 2008
Variations and gaps in management of acute asthma in Ontario emergency departmentsM Diane Lougheed, Nancy Garvey, Kenneth R Chapman, et al.
British Journal of Clinical Pharmacology|June 30, 2017
Quantitative disease progression model of α-1 proteinase inhibitor therapy on computed tomography lung density in patients with α-1 antitrypsin deficiencyMichael A Tortorici, James A Rogers, Oliver Vit, et al.
Chest|March 5, 2023
Impaired Spirometry and COPD Increase the Risk of Cardiovascular Disease: A Canadian Cohort StudySuurya Krishnan, Wan C Tan, Raquel Farias, et al.
The Journal of Allergy and Clinical Immunology|November 16, 2025
Transient early blood eosinophil increases do not affect dupilumab's long-term efficacy in patients with moderate-to-severe asthmaIan D Pavord, Njira L Lugogo, Mario Castro, et al.
Pageof 18

Showing results (131-140 of 176) with videos related to

Sort By:
Pageof 18
Lancet (London, England)|June 1, 2015
Intravenous augmentation treatment and lung density in severe α1 antitrypsin deficiency (RAPID): a randomised, double-blind, placebo-controlled trialKenneth R Chapman, Jonathan G W Burdon, Eeva Piitulainen, et al.
The Journal of Asthma : Official Journal of the Association for the Care of Asthma|April 30, 2020
Reducing the hidden burden of severe asthma: recognition and referrals from primary practiceMarc Humbert, Arnaud Bourdin, Nikolaos G Papadopoulos, et al.
Journal of Asthma and Allergy|January 30, 2023
Mometasone/Indacaterol/Glycopyrronium (MF/IND/GLY) and MF/IND at Different MF Strengths versus Fluticasone Propionate/Salmeterol Xinafoate (FLU/SAL) and FLU/SAL+ Tiotropium in Patients with AsthmaRichard N van Zyl-Smit, Kenneth R Chapman, Huib A M Kerstjens, et al.
Respiratory Research|May 11, 2021
Benefit of switching to mepolizumab from omalizumab in severe eosinophilic asthma based on patient characteristicsMark C Liu, Bradley Chipps, Xavier Munoz, et al.
Plos One|April 5, 2013
Bronchodilator responsiveness and reported respiratory symptoms in an adult populationWan C Tan, Jean Bourbeau, Paul Hernandez, et al.
Chest|April 13, 2006
The Ontario Asthma Regional Variation Study: emergency department visit rates and the relation to hospitalization ratesM Diane Lougheed, Nancy Garvey, Kenneth R Chapman, et al.
Chest|November 20, 2008
Variations and gaps in management of acute asthma in Ontario emergency departmentsM Diane Lougheed, Nancy Garvey, Kenneth R Chapman, et al.
British Journal of Clinical Pharmacology|June 30, 2017
Quantitative disease progression model of α-1 proteinase inhibitor therapy on computed tomography lung density in patients with α-1 antitrypsin deficiencyMichael A Tortorici, James A Rogers, Oliver Vit, et al.
Chest|March 5, 2023
Impaired Spirometry and COPD Increase the Risk of Cardiovascular Disease: A Canadian Cohort StudySuurya Krishnan, Wan C Tan, Raquel Farias, et al.
The Journal of Allergy and Clinical Immunology|November 16, 2025
Transient early blood eosinophil increases do not affect dupilumab's long-term efficacy in patients with moderate-to-severe asthmaIan D Pavord, Njira L Lugogo, Mario Castro, et al.
Pageof 18